Vidipha Central Pharmaceutical

VDP

VN000000VDP2

Pharmaceuticals

End-of-day quote Ho Chi Minh S.E. Other stock markets 18:00:00 2024-07-03 EDT			5-day change	1st Jan Change
38,500 ^VND	0.00%		+0.11%	+18.46%

05-20	Vidipha Central Pharmaceutical Joint Stock Company Provides Earnings Guidance for the Year 2024	CI
05-20	Vidipha Central Pharmaceutical Joint Stock Company Approves Dividend for the Year 2023; Provides Dividend Guidance for the Year 2024	CI

Vidipha Central Pharmaceutical Joint Stock Company Provides Earnings Guidance for 2020

July 27, 2020 at 05:23 am

Vidipha Central Pharmaceutical Joint Stock Company provided earnings guidance for 2020. The company expects Total revenue of VND 750 billion, Profit before tax to be VND 60 billion.

Latest news about Vidipha Central Pharmaceutical

Vidipha Central Pharmaceutical Joint Stock Company Provides Earnings Guidance for the Year 2024	05-19	CI
Vidipha Central Pharmaceutical Joint Stock Company Approves Dividend for the Year 2023; Provides Dividend Guidance for the Year 2024	05-19	CI
Vidipha Central Pharmaceutical Joint Stock Company Announces Second Cash Dividend for 2023, Payable on May 22, 2024	01-15	CI
Vidipha Central Pharmaceutical Joint Stock Company Announces Plan for the First Dividend Payment in 2023, Payable on January 10, 2024	12-12	CI
Vidipha Central Pharmaceutical Joint Stock Company Announces Plan for the First Dividend Payment in 2023	11-08	CI
Vidipha Central Pharmaceutical Joint Stock Company announced that it has received VND 56.36748 billion in funding	23-10-25	CI
Vidipha Central Pharmaceutical Joint Stock Company announced that it has received VND 56.36748 billion in funding	23-10-25	CI
Vidipha Central Pharmaceutical Joint Stock Company announced that it expects to receive VND 107.888 billion in funding	23-07-23	CI
Vidipha Central Pharmaceutical Joint Stock Company announced that it expects to receive VND 56.36748 billion in funding	23-05-28	CI
Vidipha Central Pharmaceutical Joint Stock Company Announces Resignation of Tran Anh Tuan as Member of Supervisory Board	23-03-24	CI
Vidipha Central Pharmaceutical Joint Stock Company Announces Second Cash Dividend, Payable on May 18, 2023	23-02-03	CI
Vidipha Central Pharmaceutical Joint Stock Company Announces the First Cash Dividend for 2022, Payable on December 15, 2022	22-11-04	CI
Vidipha Central Pharmaceutical Joint Stock Company Approves the Appointment of Mrs. Dinh Thi Hoang Anh as Deputy Chief Executive Officer	22-07-22	CI
Vidipha Central Pharmaceutical Joint Stock Company Announces the First Cash Dividend for 2021, Payable on May 20, 2022	22-03-08	CI
Vidipha Central Pharmaceutical Joint Stock Company Announces the First Cash Dividend for 2020, payable on September 30, 2020	20-09-04	CI
Vidipha Central Pharmaceutical Joint Stock Company Announces Resignation of Nguyen Duc Son as Deputy Chairman of the BOD	20-08-13	CI
Vidipha Central Pharmaceutical Joint Stock Company Announces Resignation of Nguyen Duc Son as Deputy Chairman of Board of Directors	20-08-03	CI
Vidipha Central Pharmaceutical Joint Stock Company Proposes Dividend for the Year 2020	20-07-27	CI
Vidipha Central Pharmaceutical Joint Stock Company Provides Earnings Guidance for 2020	20-07-27	CI
Vidipha Central Pharmaceutical Joint Stock Company Reports Earnings Results for the Year 2019	20-07-27	CI
Vidipha Central Pharmaceutical Joint Stock Company Announces the Resignation of Nguyen Quang Toan as Head of Supervisory Board	20-06-02	CI
Vidipha Central Pharmaceutical Joint Stock Company Announces Dividend Payment for 2019, Payable on June 15, 2020	20-03-17	CI
Vidipha Central Pharmaceutical Joint Stock Company Announces Dividend Payment for 2018, Payable on May 22, 2019	19-03-08	CI
Vidipha Central Pharmaceutical Joint Stock Company Provides Earnings Guidance for the Year 2018	18-05-09	CI
Vidipha Central Pharmaceutical Joint Stock Company Announces the Retirement of Deputy CEO Nguyen Ngoc Tuan	18-03-05	CI

Chart Vidipha Central Pharmaceutical

Duration

Period

More charts

Vidipha Central Pharmaceutical Joint - Stock Company is a Vietnam-based company primarily engaged in the pharmaceuticals sector. The Company's leading business activity is the manufacture of pharmaceuticals in various forms, such as tablet, liquid, powder and ointment. The Company's products include antibiotics, anti-inflammatory drugs, vitamins, minerals, pain killers, antipyretics and antihistamines, among others.

Sector

Pharmaceuticals

More about the company

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
VIDIPHA CENTRAL PHARMACEUTICAL	+18.46%	33.4M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+23.70%	44.09B
OTSUKA HOLDINGS CO., LTD.	+30.04%	23.18B
SANDOZ GROUP AG	+24.02%	15.66B
CIPLA LIMITED	+18.81%	14.35B
ZYDUS LIFESCIENCES LIMITED	+64.98%	13.2B
THE MEDICINES COMPANY	-0.05%	6.79B
ONO PHARMACEUTICAL CO., LTD.	-11.78%	6.45B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+14.11%	5.63B

Generic Pharmaceuticals